| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy
|
Verburg, Frederik A.
|
|
2017
|
44 |
10 |
p. 1611-1613
|
artikel
|
| 2 |
Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma
|
Lin, Huan-Chun
|
|
2017
|
44 |
10 |
p. 1702-1711
|
artikel
|
| 3 |
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
|
Fanti, Stefano
|
|
2017
|
44 |
10 |
p. 1622-1635
|
artikel
|
| 4 |
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence
|
Uprimny, Christian
|
|
2017
|
44 |
10 |
p. 1647-1655
|
artikel
|
| 5 |
Effects of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 (HBED-CC) PET/MRI
|
Afshar-Oromieh, Ali
|
|
2017
|
44 |
10 |
p. 1636-1646
|
artikel
|
| 6 |
Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
|
Afshar-Oromieh, Ali
|
|
2017
|
44 |
10 |
p. 1781
|
artikel
|
| 7 |
F-18 FDG and F-18 Tau PET in posterior cortical atrophy
|
Tripathi, Madhavi
|
|
2017
|
44 |
10 |
p. 1779-1780
|
artikel
|
| 8 |
[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type
|
Shen, Wei-Chih
|
|
2017
|
44 |
10 |
p. 1721-1731
|
artikel
|
| 9 |
68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging
|
Yamaga, Lilian Yuri Itaya
|
|
2017
|
44 |
10 |
p. 1695-1701
|
artikel
|
| 10 |
Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI
|
Kirchner, Julian
|
|
2017
|
44 |
10 |
p. 1742-1750
|
artikel
|
| 11 |
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
|
Bräuer, Axel
|
|
2017
|
44 |
10 |
p. 1663-1670
|
artikel
|
| 12 |
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer
|
Grkovski, Milan
|
|
2017
|
44 |
10 |
p. 1682-1691
|
artikel
|
| 13 |
Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging
|
Schiller, Kilian
|
|
2017
|
44 |
10 |
p. 1656-1662
|
artikel
|
| 14 |
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies
|
Giovacchini, Giampiero
|
|
2017
|
44 |
10 |
p. 1751-1776
|
artikel
|
| 15 |
Players of ‘hypoxia orchestra’ – what is the role of FMISO?
|
Toyonaga, Takuya
|
|
2017
|
44 |
10 |
p. 1679-1681
|
artikel
|
| 16 |
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
|
Du, Yong
|
|
2017
|
44 |
10 |
p. 1671-1678
|
artikel
|
| 17 |
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
|
Klein Nulent, Thomas J. W.
|
|
2017
|
44 |
10 |
p. 1614-1621
|
artikel
|
| 18 |
Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
|
Paganelli, Giovanni
|
|
2017
|
44 |
10 |
p. 1777-1778
|
artikel
|
| 19 |
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?
|
Maffione, Anna Margherita
|
|
2017
|
44 |
10 |
p. 1692-1694
|
artikel
|
| 20 |
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence
|
Angelini, Andrea
|
|
2017
|
44 |
10 |
p. 1712-1720
|
artikel
|
| 21 |
The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
|
Li, Shuren
|
|
2017
|
44 |
10 |
p. 1732-1741
|
artikel
|
Tijdschrift beschrijving